(Q54516081)
Statements
Metronomic chemotherapy combined with bevacizumab and erlotinib in patients with metastatic HER2-negative breast cancer: clinical and biological activity. (English)
Giuseppe Viale
Aron Goldhirsch
Silvia Dellapasqua
Alberto Luini
Marco Colleoni
Mattia Intra
Emilia Montagna
Cristiano Rampinelli
Giuseppe Cancello
Vincenzo Bagnardi
Davide Pastrello
Gino Perri
Paolo Veronesi
Angelica Calleri
Francesco Bertolini
20 April 2012
12
3
207-214